Revised guidelines for amyloid and tau positron emission tomography for Alzheimer’s disease and dementia state these tests ...
A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...
Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...
Study reveals surprising connection between common childhood virus CMV and Alzheimer's disease, offering new insights into ...
A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...
Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...
When we think about dementia, we often think of a person experiencing memory loss and confusion. While it’s true that these ...
POTOMAC, MD / ACCESSWIRE / January 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") announced today that its ongoing Phase 2 trial for agitation in Alzheimer's disease ...
A new study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate groups and proposed an explanation for how cognitive impairment arises. The ...
INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...
Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.